A clinical trial of HLX-1502
Latest Information Update: 19 Apr 2024
At a glance
- Drugs HLX 1502 (Primary)
- Indications Neurofibromatosis 1
- Focus Adverse reactions
Most Recent Events
- 19 Apr 2024 New trial record
Latest Information Update: 19 Apr 2024